Q Aarne Aktan, CEO
|
|
- Shanon Arnold
- 5 years ago
- Views:
Transcription
1 Q Aarne Aktan, CEO
2 Q3: P&S EXCELLENT, C&S IN LINE WITH EXPECTATIONS Revenue grew by 6 per cent, organic growth by 2 per cent Revenue growth mainly attributable to Social and Healthcare Outsourcings, Surgical Operations and Public Specialised Care and Private Clinics P&S segment s EBITDA grew by 49 per cent, EBIT by 44 per cent In C&S, both EBITDA and EBIT decreased slightly compared to last year 10,0 8,0 6,0 4,0 2,0 0,0 Group Key Figures, EUR million Q3/2016 Q4/2016 Q1/2017 Q2/2017 Q3/2017 EBITDA EBIT Revenue 120,0 100,0 80,0 60,0 40,0 20,0 0,0 2
3 Q3: EXPECTATIONS VS. ACTUALIZED Occupational Healthcare Surgical Operations Public Specialised Care Dental Care Private Clinics P&S Other Social and Healthcare Outsourcings 3
4 GROUP S OPERATIONAL PROJECTS Q3 Q4 PROMISED DELIVERED WE PROMISE MAIN Begin the brand campaign Expedite the GF project Launch Group s new website and online appointment system Completed first phase of brand campaign Launched new website and appointment system Greenfield project on time Optimize and further develop the online appointment system Enhance the application, launch to new groups MID Launch new data management systems applications Enhance the Pihlajalinna application Launch new data management systems applications Pihlajalinna application s enhancement underway Launch new data management systems applications Develop new Occupational Healthcare portal LOW Launch HR platform Sympa to personnel Further develop the robotics pilot projects HR platform s launch to employees postponed to Q4 Further developed the robotics pilot projects Launch HR platform Sympa to personnel Enhance the performance of the patient information system 4
5 LEGISLATION AND MARKET REVIEW 1/2 The government presented the new legislative proposal concerning the Act on Freedom of Choice in October After the circulation for comments, the proposal is expected to be handed to the parliament at the beginning of March 2018 The Act on Freedom of Choice, the Act on Organising Health and Social Services and the Counties Act will be considered simultaneously in the parliament The Ministry of Social Affairs and Health estimates that the size of the freedom-ofchoice market would be, at minimum, EUR 5.8 billion health and social services centres roughly EUR 2 billion service vouchers roughly EUR 2 billion personal budgets at least EUR 1.4 billion dental care units roughly EUR 0.4 billion 5
6 LEGISLATION AND MARKET REVIEW 2/2 The Act on Organising Health and Social Services and the Act of Freedom of Choice are intended to take effect on 1 January 2020 Personal budgets would come into force on 1 January 2020 Service vouchers should be adopted no later than on 1 July 2020, regional governments should take service vouchers into use in certain specialised care services no later than on 1 January 2022 The health and social services centres would begin operating on 1 January 2021, dental care units on 1 January 2022 The current municipal outsourcing market has been very active due to the postponement of the health and social services reform, but many municipalities are waiting for the final content of the legislative reform in terms of their decision-making Ongoing tendering processes: Hattula, Rautalampi, Iisalmi (hospital) 6
7 7
Pihlajalinna Q4. CEO Aarne Aktan 17 February 2017
Pihlajalinna Q4 CEO Aarne Aktan 17 February 2017 Revenue developed as expected M 2004 2016 CAGR +46 % 399,1 0,2 1,4 4,1 5,8 8,3 11,9 16,9 20,1 31,0 42,1 47,3 104,4 148,9 213,3 2002 2003 2004 2005 2006
More informationPihlajalinna Q3. CEO Aarne Aktan 11 November 2016
Pihlajalinna Q3 CEO Aarne Aktan 11 November 2016 Revenue outlook adjusted M 2004 2015 CAGR +43% 400,0 0,2 1,4 4,1 5,8 8,3 11,9 16,9 20,1 31,0 42,1 47,3 104,4 148,9 213,3 2002 2003 2004 2005 2006 2007 2008
More informationPihlajalinna H1. CEO Aarne Aktan. 17 August 2016
Pihlajalinna H1 CEO Aarne Aktan 17 August 2016 Q2 Revenue grew, profitability improved 101.4 7.0 3.5 Revenue, EUR million Increase 95%, 49.4 EUR million EBITDA, EUR million Increase 236%, 4.9 EUR million
More informationHALF YEAR FINANCIAL REPORT 1 January 30 June 2017
HALF YEAR FINANCIAL REPORT 1 January 30 June 2017 Pihlajalinna Half Year Financial Report 1 January 30 June 2017 (6 months) Soft second quarter for Private Clinics and Specialised Care, strong profitability
More informationINTERIM REPORT 1 January 31 March 2017
INTERIM REPORT 1 January 31 March 2017 Pihlajalinna Interim Report 1 January 31 March 2017 (3 months) Profitability improvement continued, Pihlajalinna prepares for the healthcare and social welfare reform
More informationCAPITAL MARKETS DAY. Glo Hotel Kluuvi, Helsinki, 22 November 2017
CAPITAL MARKETS DAY Glo Hotel Kluuvi, Helsinki, 22 November 2017 STRATEGY CEO Aarne Aktan STRATEGY REVISED Mission We help Finns to live a better life Vision The most valued healthcare and social services
More informationGroup. better tomorrow. Interim Report 1 January 30 September 2016
Group better tomorrow Q3 Interim Report 1 January 30 September 2016 Pihlajalinna Interim Report 1 January 30 September 2016 (9 months) Profitable growth continued, revenue outlook adjusted Brief look at
More informationINTERIM REPORT 1 January 30 September 2017
INTERIM REPORT 1 January 30 September 2017 Pihlajalinna Interim Report 1 January 30 September 2017 (9 months) Strong third quarter in Primary and Social Care Brief look at July September: Revenue amounted
More information2018 THE YEAR OF GROWTH. Joni Aaltonen CEO
2018 THE YEAR OF GROWTH Joni Aaltonen CEO 2018: REVENUE INCREASED SUBSTANTIALLY Revenue amounted to EUR 487.8 (424) million an increase of 15 per cent EBITDA amounted to EUR 31.2 (33.3) million Adjusted
More informationGroup. better tomorrow
Group better tomorrow Financial Statements Release 1 January 31 December 2016 Pihlajalinna Financial Statements Release 1 January 31 December 2016 (12 months) Revenue and profitability for the financial
More informationGroup. better tomorrow. Group
better tomorrow Q1 Pihlajalinna Interim Report 1 January 31 March 2016 Pihlajalinna Interim Report 1 January 31 March 2016 (3 months) Consolidated operating profit improved, revenue growth continued Brief
More informationHALF YEAR FINANCIAL REPORT 1 January 30 June 2018
HALF YEAR FINANCIAL REPORT 1 January 30 June 2018 Pihlajalinna Half Year Financial Report 1 Jan 30 Jun 2018 (6 months) Pihlajalinna s result weighed down by expansion and structural reforms Brief look
More informationGroup. better tomorrow
better tomorrow Interim report January June 2015 2 Pihlajalinna Interim Report 1 January 30 June 2015 Pihlajalinna: Interim Report 1 January 30 June 2015 (6 months) Strong revenue growth continued, investing
More informationGroup. better tomorrow. Interim report January September Group
better tomorrow Interim report January September 2015 2 Interim Report 1 January 30 September 2015 Pihlajalinna: Interim Report 1 January 30 september 2015 (9 months) Strong revenue growth continued, investments
More informationPIHLAJALINNA Health Care/Finland, April 4, 2017 Company report
Price/EUR Initiating coverage with Buy rating Rating PIHLAJALINNA BUY Pihlajalinna has good prerequisites to continue solid success in outsourcings in the short term, and the upcoming SOTE reform is expected
More informationFINANCIAL STATEMENTS RELEASE 1 January 31 December 2018
FINANCIAL STATEMENTS RELEASE 1 January 31 December 2018 Pihlajalinna Financial Statements Release 1 Jan 31 Dec 2018 (12 months) Pihlajalinna s revenue for the financial year increased substantially, actions
More informationADJUSTED EBITDA. NET DEBT/ EBITDA Dec 2018 (31 Dec 2017: 1.0) EUR million (2017: 33.3) target below 3
ANNUAL REPORT YEAR Contents Pihlajalinna in brief...1 From the Chairman of the Board of Directors...4 From the CEO...5 Operational environment...6 Business and strategy...8 Presentation of business areas...10
More informationGroup. better tomorrow
better tomorrow Financial Statements Bulletin 1 jan 31 dec 2015 2 Pihlajalinna Financial Statements bulletin 1 January 31 December 2015 (12 Months) Pihlajalinna Financial Statements bulletin 1 January
More informationContents OPERATING PROFIT (EBIT) 19.1 EUR million (2016: 15.1) 26% in 2017 EARNINGS PER SHARE 0.46 EUR (2016: 0.39) 18% Timeline
2017 PIHLAJALINNA 2017 Pihlajalinna in brief... 1 From the Chairman of the Board of Directors...2 From the CEO...3 Operational environment... 4 Business and strategy...8 Contents Segments... 10 Responsibility...12
More informationINTERIM REPORT 1 January 30 September 2018
INTERIM REPORT 1 January 30 September 2018 Pihlajalinna Interim Report 1 Jan 30 Sep 2018 (9 months) Pihlajalinna s profitability is improving, outlook unchanged Brief look at July September: Revenue amounted
More informationOrdinary General Shareholders' Meeting of
Ordinary General Shareholders' Meeting of 8 May 2018 Speech by the CEO Marcelino Fernández Verdes Introduction Fellow shareholders, good morning and many thanks for attending this General Shareholders'
More informationFortis Healthcare Limited Investor Presentation Q4 & FY13. Saving and Enriching Lives
Fortis Healthcare Limited Investor Presentation Q4 & Saving and Enriching Lives May 30, 2013 Disclaimer This presentation may not be copied, published, distributed or transmitted. The presentation has
More informationUDG Healthcare plc Interim Results Presentation FY17. London Stock Exchange, 23 rd May 2017
UDG Healthcare plc Interim Results Presentation FY17 London Stock Exchange, 23 rd May 2017 Forward looking statements This Presentation has been prepared by UDG Healthcare plc and contains certain forward-looking
More information12,5 M 100 % 15 v 399,8 M 310,4 M (225,5 M ) (8,6 M ) ( 100 %) (292,3 M ) (14,3 y) Total revenue. Occupancy rate. Value of portfolio agreement
1-9/2018 (1-9/2017) Total revenue 12,5 M (8,6 M ) 15 10 5 0 1-9/2017 1-9/2018 Value of investment properties 310,4 M (225,5 M ) Occupancy rate 100 % ( 100 %) Value of portfolio agreement 399,8 M (292,3
More information1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017
1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017 GROUP RESULTS 2 GROWTH IN PROFIT AND FCF Group Underlying 1 Reported 2 1H 2018 1H 2017 1H 2018 1H 2017 Revenue 856.5 808.7 856.5 808.7 EBIT 81.3 81.9 61.6 61.1
More informationFinancial and Operational Review
Financial and Operational Review For the year ended 30 June 2018 Colin Goldschmidt CEO, Sonic Healthcare 16 August 2018 Forward-looking statements This presentation may include forward-looking statements
More informationANNUAL GENERAL MEETING. Tampere April 4th, 2019 Joni Aaltonen CEO
ANNUAL GENERAL MEETING Tampere April 4th, 2019 Joni Aaltonen CEO PIHLAJALINNA IN BRIEF One of the leading private social and healthcare service providers in Finland Headquarter in Tampere Market leader
More informationOrganisation for Economic Co-operation and Development DAF/COMP/WP2/WD(2018)32
Organisation for Economic Co-operation and Development DAF/COMP/WP2/WD(2018)32 DIRECTORATE FOR FINANCIAL AND ENTERPRISE AFFAIRS COMPETITION COMMITTEE English - Or. English 8 November 2018 Working Party
More informationConference Call Presentation for 2016 Preliminary Unaudited Consolidated Annual Financial Results
Conference Call Presentation for 2016 Preliminary Unaudited Consolidated Annual Financial Results LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation
More informationDANISH MINISTRY OF BUSINESS AND GROWTH
DANISH MINISTRY OF BUSINESS AND GROWTH REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 CONCERNING THE OPERATION OF SERVICES OF GENERAL ECONOMIC INTEREST (SGEI) June 2014
More information2018 Half Year Results Presentation. 18 September 2018
2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including
More information2Q12 Results FLRY 3. August, 2012
2Q12 Results FLRY 3 August, 2012 ALL RIGHTS RESERVED 2012 Disclaimer This presentation may contain forward-looking statements. Such statements are not statements of historical facts and reflect the beliefs
More informationBioservo Technologies AB Interim report, January-June 2018
Bioservo Technologies AB Interim report, January-June 2018 Second quarter of 2018 in brief Net sales rose to SEK 1.6 M (0.6) EBITDA amounted to SEK -4.0 M (-4.7) EBIT totalled SEK -4.7 M (-5.1) Bioservo
More informationGLOBAL HEALTH PARTNER Q4 REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO
REPORT Daniel Öhman, CEO Tobias Linebäck, CFO and Dep. CEO performance CEO comments Agenda and Full year financials Summary and future Improved performance in SEK millions REVENUES Revenues at 208 (206)
More informationQ Strong start for Kimmo Alkio, President and CEO Lasse Heinonen, CFO Tanja Lounevirta, Head of IR. 26 April 2018.
Public Q1 218 Strong start for 218 Kimmo Alkio, President and CEO Lasse Heinonen, CFO Tanja Lounevirta, Head of IR 26 April 218 Q1 218 in brief Strong start for 218 Growth in local currencies 6%, organically
More informationSecond Quarter July 28 th, Tom Rönnlund, CEO
Second Quarter 2017 July 28 th, 2017 Tom Rönnlund, CEO AGENDA Agenda Q2 highlights and key figures Pharma & Healthcare commercial update Medtech commercial update Financials Outlook Navamedic 2 Q1 HIGHLIGHTS
More informationFourth Quarter 2016 Presentation. 15 February, 2017
Fourth Quarter 2016 Presentation 15 February, 2017 Henrik Borelius, CEO Tomas Björksiöö, CFO 2 Financial summary of Q4: Continued stable development Net sales SEK 2,647m (2,564), adjusted growth 4% Operating
More informationINTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,)
INTERNATIONAL HEALTH SYSTEMS: THE ASIAN (TAIWAN, JAPAN, SINGAPORE,) Presented by: Ms. Nuanthip Tangsitchanakun 5749173 Ms. Nan Nin Shwe Yi Lin 5849104 HEATH CARE SYSTEMS JAPAN IN OVERVIEW OF JAPAN HEALTHCARE
More information2Q19 Results Presentation. 11 February 2019
2Q19 Results Presentation 11 February 2019 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given
More informationThird Quarter 2016 Presentation. 11 November, 2016
Third Quarter 2016 Presentation 11 November, 2016 Henrik Borelius, CEO Tomas Björksiöö, CFO 2 Financial summary of Q3: Continued stable development Net sales SEK 2.6bn (2.5), growth 5%, adjusted growth
More informationWEB CAST PRESENTATION
WEB CAST PRESENTATION interim report Fredrik Rågmark, CEO & Joe Ryan, CFO Stockholm 27 July, DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain certain forward-looking statements
More informationHealthcare in China The Opportunity for Investment. Chindex International and United Family Healthcare February 2010
Healthcare in China The Opportunity for Investment Chindex International and United Family Healthcare February 2010 Forward Looking Statements This presentation contains information which may be considered
More informationQuality through specialisation Q3 REPORT. October 25, Daniel Öhman, CEO Philip Delborn, CFO
Quality through specialisation REPORT October 25, 2018 Daniel Öhman, CEO Philip Delborn, CFO 2 Agenda CEO reflections on Financials Quality outcomes 3 12,3% organic growth in the third quarter MSEK Revenues
More informationRAMSAY HEALTH CARE LIMITED Annual General Meeting 20 November 2001
Annual General Meeting 20 November 2001 Chairman s Overview! Strong year of growth in Australian private hospital sector! Operating environment conducive to further growth for Ramsay! Ramsay reports record
More informationPublic sector pensions
Public sector pensions ANNUAL REPORT 2017 Table of contents CEO s review 3 Report of the Board of Directors 2017 4 Operating environment 4 Economic outlook strengthened in 2017 5 Changes in legislation
More informationMLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018
MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018 MLP Overview Dr. Muharrem Usta Chairman and CEO 2 Summary Results above our expectations Growth across all segments Double digit growth in Net
More informationHALF YEAR RESULTS PRESENTATION
HALF YEAR RESULTS PRESENTATION 6 MONTHS ENDED 30 JUNE 2013 7 August 2013 1 www.bupa.com AGENDA 1.0 Introduction and Highlights Stuart Fletcher, Chief Executive Officer 2.0 Financial Review Evelyn Bourke,
More informationRevenue up 6.1% in the third quarter of 2018
PRESS RELEASE Paris, 24 October 2018 Revenue up 6.1% in the third quarter of 2018 Sustained growth in France: 3.6% in the third quarter Strong growth internationally: 8.7% in the third quarter Continued
More informationActivities Implemented to Date 1. FOREIGN DIRECT INVESTMENT POLICIES AND PROGRAMMES
MONTENEGRO 101 Summary The activities of the Government of in 2000 were aimed at transformation and privatisation of the economy and the establishment of the structural preconditions for a functioning
More informationANNUAL REPORT 5 FEBRUARY 2015
ANNUAL REPORT 2014 5 FEBRUARY 2015 Agenda 2014 in outline Focus and expectations 2015 Financial development 2014 Development of companies 5 February 2015 2 Successful growth of No Ads+ is the most important
More informationREPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST
Logo: Ministry of Business and Growth Denmark REPORT ON DENMARK S APPLICATION OF THE COMMISSION DECISION OF 20 DECEMBER 2011 ON SERVICES OF GENERAL ECONOMIC INTEREST June 2016 2/14 CONTENTS Introduction
More informationPRESS RELEASE TBS Group: the Board of Directors approves the interim financial report as of 30 September 2015
PRESS RELEASE TBS Group: the Board of Directors approves the interim financial report as of 30 September 2015 Consolidated revenue of 171.8 million euro, up 3.6 million compared to 30 September 2014 (+2.1%)
More informationMunicipality Finance Plc Financial Statements Bulletin
14 February 2018, at 4:00 p.m. Municipality Finance Plc Financial Statements Bulletin 1 JANUARY 31 DECEMBER 2017 2017 in Brief The Group s net interest income grew by 10.9% year-on-year, totalling EUR
More informationMedistim ASA Second Quarter Kari E. Krogstad, President and CEO Thomas Jakobsen, CFO August 20th, 2013
Medistim ASA Second Quarter 2013 Kari E. Krogstad, President and CEO Thomas Jakobsen, CFO August 20th, 2013 2 20.08.2013 Medistim ASA 2013 Disclaimer The information included in this Presentation contains
More informationNordic and France continue the good performance. Enhanced focus on digitalization and specialization.
Capio AB (publ) Interim report Jan Jun 2018 April June 2018 Net sales MSEK 4,179 (3,881). Organic sales growth 1.6% (0.5) and total sales growth 7.7% (8.6) EBITDA 1 MSEK 262 (256) and margin 6.3% (6.6).
More informationCleopatra Hospitals Company Reports 2Q2016 Results
Cleopatra Hospitals Company Reports 2Q2016 Results 2Q2016 Financial and Operational Highlights 1 EGP 201.7 million Total consolidated revenue EGP 42.0 million EBITDA (21% margin) EGP 20.7 million Net Income
More information30 MAY First quarter 2018 PRESENTED BY TOM RÖNNLUND, CEO Q1 2018
30 MAY 2018 First quarter 2018 PRESENTED BY TOM RÖNNLUND, CEO Q1 2018 Q1 Summary Navamedic reported revenues of NOK 42.6 million, compared to NOK 78.2 in Q1 2017 The Q1 2018 revenues decreased by 4.0 %
More informationPIHLAJALINNA Health Care/Finland, February 25, 2019 Company update
Price/EUR More favorable outlook for 2019E Rating BUY Pihlajalinna s organic growth, profitability and outlook for 2019E improved towards the end of 2018. The new contract pipeline improved somewhat, and
More informationAnnual General Meeting Stuttgart, 16 May 2012
Annual General Meeting 2012 Stuttgart, 16 May 2012 Development in earnings at Celesio Earnings before tax* from 1987-2007 * Since 2003 according to IAS standards Development in earnings at Celesio Earnings
More informationORIOLA. ORIOLA CORPORATION January June 2017 Eero Hautaniemi, President and CEO 21 July Oriola Corporation
ORIOLA ORIOLA CORPORATION January June Eero Hautaniemi, President and CEO 21 July 1 April June highlights 2 Consumer Q2 result did not reach previous year level Online sales grew by 91% in Q2 In Services
More informationFinal Results 9M & Q3 2018
Final Results 9M & Q3 2018 Georg Hesse (CEO) Nate Glissmeyer (CPO/CTO) Markus Scheuermann (CFO) November 8 th 2018 1. Overview 9M & Q3 2018: In line with our expectations Market development Central-European
More informationReport: Financial situation of hospitals Summary. Łódź,
Report: Financial situation of hospitals Summary Łódź, 18.12.2017 Magellan - an expert on the market of financial services for the medical sector Healthcare market research Magellan has been studying market
More informationMEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT
HOW HEALTH SYSTEMS CAN THRIVE WITH MEDICARE ADVANTAGE The 2019 Medicare Advantage (MA) plan year began on January 1st and once again more Americans enrolled in MA plans than the year before. Fueled by
More informationForward Looking Statements
MLP Care 1Q2018 Presentation 8 May 2018 Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care s future performance and should be considered as
More informationRaisio s Financial Statements President and CEO Pekka Kuusniemi Raisio plc 12 February 2018
Raisio s Financial Statements 2017 President and CEO Pekka Kuusniemi Raisio plc 12 February 2018 Group net sales and EBIT Continuing and discontinued operations M 500 400 300 200 100 0 Net sales 436.3
More information17. Communication, Dissemination and Exploitation
HORIZON 2020 WORK PROGRAMME 2014 2015 17. Important Notice on the First Horizon 2020 Work Programme This Work Programme covers 2014 and 2015. Due to the launching phase of Horizon 2020, parts of the Work
More informationFinancial and Operational Review
Financial and Operational Review For the year ended 30 June 2016 Colin Goldschmidt CEO, Sonic Healthcare 17 August 2016 Forward-looking statements This presentation may include forward-looking statements
More informationMorgan Stanley Australian Emerging Companies Conference
Morgan Stanley Australian Emerging Companies Conference John Livingston (CEO) Craig Bremner (CFO) 15 June 2016 ATTRACTIVE BUSINESS MODEL 1 IDX BUSINESS MODEL The combination of IDX's referrers, sites,
More informationFirst quarter 2017 Presentation. 5 May, 2017
First quarter 2017 Presentation 5 May, 2017 Henrik Borelius, CEO Tomas Björksiöö, CFO Financial summary of : Continued stable development Net sales SEK 2,661m (2,472), adjusted growth 6% Operating profit
More informationRight care. Right time. Right place.
Right care. Right time. Right place. Amedisys Investor Presentation June 2016 0 Forward-looking Statements This presentation may include forward-looking statements as defined by the Private Securities
More informationLong-term care Dilemmas concerning sustainable financing (Ljubljana, November 2014) 1
Long-term care Dilemmas concerning sustainable financing (Ljubljana, 18-19 November 2014) 1 Heino Jespersen The National Social Appeals Board This paper briefly describes the organisation and funding of
More information4Q18 Results Presentation. 27 August 2018
4Q18 Results Presentation 27 August 2018 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given in
More informationirobot Second-Quarter 2014 Conference Call Script
irobot Second-Quarter 2014 Conference Call Script Operator: Good day everyone and welcome to the irobot second-quarter 2014 financial results conference call. This call is being recorded. At this time
More informationInterim FY 2015 results 6 months ended 31 December February 2015
Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights
More informationHalf Year 2016 Results Presentation
Half Year 2016 Results Presentation EYE CARE, WE CARE MORE 5 August 2016 Forward looking statements This presentation contains forward-looking statements that reflect GrandVision s current views with respect
More informationInterim Report. 1 July September 2006
Interim Report 1 July 2006 30 September 2006 1 Q3 2006 Report President and CEO Veli-Matti Mattila Elisa Q3 2006 Q3 2006 and financial highlights Review of the mobile and fixed network businesses Execution
More informationHealthcare in China The Opportunity for Investment. Chindex International and United Family Healthcare November 2010
Healthcare in China The Opportunity for Investment Chindex International and United Family Healthcare November 2010 Forward Looking Statements This presentation contains information which may be considered
More informationSlovenia. Health Care & Long-Term Care Systems
Slovenia Health Care & Long-Term Care Systems An excerpt from the Joint Report on Health Care and Long-Term Care Systems & Fiscal Sustainability, published in October 2016 as Institutional Paper 37 Volume
More informationQ May 10, Tom Rönnlund, CEO
Q1 2017 May 10, 2017 Tom Rönnlund, CEO AGENDA Agenda Q1 highlights and financials Pharma & Healthcare commercial update Medtech commercial update Outlook 10.05.2017 Navamedic 2 Q1 HIGHLIGHTS Q1 Highlights
More informationSt. Joseph s Health Centre
Financial statements of St. Joseph s Health Centre Table of contents Independent Auditor s Report... 1-2 Statements of financial position... 3 Statements of operations... 4 Statements of changes in net
More informationCFA Society of Houston Luncheon. February 22, 2017
CFA Society of Houston Luncheon February 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included are statements
More informationQ1 report. Richard Hausmann. Gustaf Salford. August 23, President and CEO CFO
Q1 report August 23, 2017 Richard Hausmann President and CEO Gustaf Salford CFO Important information This presentation includes forward-looking statements including, but not limited to, statements relating
More informationBoule Diagnostics AB Company presentation and Q2 report August 25, 2017
Boule Diagnostics AB Company presentation and Q2 report August 25, 2017 Fredrik Dalborg, CEO and Group President 2017-08-25 BOULE DIAGNOSTICS (1) Copyright 2013, Boule Medical AB Q2 2017 in summary Tender
More informationREPORT CONVENTION (NO. 130) CONCERNING MEDICAL CARE AND SICKNESS BENEFITS, 1969
NORWAY REPORT for the period ending 30 June 2016 made by the Government of Norway, in accordance with article 22 of the Constitution of the International Labour Organisation, on the measures taken to give
More informationFull Year Results to 31 January 2018 Announced 22 March 2018
Sigma Healthcare Limited Full Year Results to 31 January 2018 Announced 22 March 2018 ASX Ticker: SIG Important Notice The material provided is a presentation of general information about Sigma s activities
More informationGovernment R&D funding in the state budget 2018
Science, Technology and Information Society 2018 Government R&D funding in the state budget 2018 R&D funding grows in the 2018 budget According to Statistics Finland, allocations for research and development
More informationceo S MeSSaGe Claims trend Quality assurance and change work 181
CEO s message Claims trend Sickness-related absence continued to decline in Sweden in 2007. The total sickness rate in the national insurance system (expressed as the number of days in which sickness benefits,
More informationCommittee on Budgetary Control
European Parliament 2014-2019 Committee on Budgetary Control 2017/2152(DEC) 24.1.2018 DRAFT REPORT on discharge in respect of the implementation of the budget of the European Agency for Safety and Health
More informationSt. Joseph s Health Centre
Financial statements of St. Joseph s Health Centre Table of contents Independent Auditor s Report... 1-2 Statement of financial position... 3 Statement of operations... 4 Statement of changes in net assets...
More informationPress Release. ProSiebenSat.1 continues its growth in the second quarter of 2012
Press Release ProSiebenSat.1 continues its growth in the second quarter of Page 1 Consolidated revenues increased by 4.5% to EUR 723.3 million Revenues in the Digital & Adjacent segment grow by 15.5% to
More informationQ1 interim report 2016/17 October 1 December CEO Lars Marcher CFO Michael Højgaard Conference call: February
Q1 interim report 2016/17 October 1 December 31 2016 CEO Lars Marcher CFO Michael Højgaard Conference call: February 1 2017 Agenda Q1 highlights ascope update Financials and outlook Q&A Disclaimer Forward-looking
More information1H18 RESULTS. EBITDA MARGIN expands to 10.3% ; Outlook confirmed. Jan De Witte & Ann Desender. 19 July 2018
1H18 RESULTS EBITDA MARGIN expands to 10.3% ; Outlook confirmed Jan De Witte & Ann Desender 19 July 2018 All definitions for Alternative Performance Measures (APM s) are available in the half year report
More informationQ Second Quarter 2016
Q2 2016 Second Quarter 2016 Highlights for the second quarter of 2016 o Group sales increased with NOK 3.8 million from NOK 11.5 million in the first quarter of 2016 to NOK 15.3 million in the second quarter
More informationHSBC GEMs Investor Forum London 3 4 September 2018
HSBC GEMs Investor Forum 2018 - London 3 4 September 2018 Disclaimer This presentation may contain certain forward-looking statements concerning MLP Care s future performance and should be considered as
More informationContent. 05 May Memorandum. Ministry of Health and Social Affairs Sweden. Strategic Social Reporting 2015 Sweden
Memorandum 05 May 2015 Ministry of Health and Social Affairs Sweden Strategic Social Reporting 2015 Sweden Content 1. Introduction... 2 2. Delivering on the Europe 2020 objective to combat poverty and
More informationQ Complementary Summary of Omnicell Q Results: October 31, 2013
Q3 10-31-13 Complementary Summary of Omnicell Q3 Results: October 31, This complementary summary of Omnicell financial results includes forward-looking statements subject to risks, uncertainties and other
More informationJanuary-September 2016 Business Review CEO Heikki Väänänen & CFO Sixten Hjort
January-September 2016 Business Review CEO Heikki Väänänen & CFO Sixten Hjort Q3 Highlights: profitability improved, net sales at last year s level, negotiations about Anttila store space proceeding Profitability
More informationFinancing of innovation projects
Financing of innovation projects Financing of innovation and business-related projects If you have ideas for an innovation project you want to carry out, you often find that you reach a point where you
More informationMunicipality Finance Plc Financial Statements Bulletin
9 February 2016 at 2 p.m. Municipality Finance Plc Financial Statements Bulletin 1 January 31 December 2015 2015 in Brief: The Group s net operating profit amounted to EUR 151.8 million (2014: EUR 144.2
More informationAlma Media Q4 and FY2014. Kai Telanne, President and CEO Juha Nuutinen, CFO 13 February 2015
Alma Media Q4 and FY2014 Kai Telanne, President and CEO Juha Nuutinen, CFO 13 February 2015 Agenda Highlights Market development Financial development Dividend proposal Strategy and outlook Q & A 2 Q4/2014
More information